Effects of interferon-γ knockdown on vaccine-induced immunity against marek’s disease in chickens

Canadian Journal of Veterinary Research

Volumn 79, Issue 1, 2015, Pages 1-7

  Haq, Kamran ^a   Wootton, Sarah K ^a   Barjesteh, Neda ^a   Golovan, Serguei ^b   Bendall, Andrew ^c   Sharif, Shayan ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF DELAWARE   (United States)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GAMMA INTERFERON; RNA DIRECTED DNA POLYMERASE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; BIOLOGICAL MARKER; VIRUS VACCINE;

ARTICLE; AUTOPSY; CANCER INCIDENCE; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; GENETIC REGULATION; HUMAN; HUMAN CELL; IMMUNITY; MAREK DISEASE; MUSCLE ATROPHY; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; VACCINATION; VIRUS RECOMBINANT; ANIMAL; CHICKEN; EVALUATION STUDY; GENE SILENCING; GENETICS; IMMUNOLOGY; POULTRY DISEASES;

AVES; AVIAN ADENO-ASSOCIATED VIRUS; GALLUS GALLUS; MELEAGRID HERPESVIRUS 1;

ANIMALS; BIOMARKERS; CHICKENS; GENE KNOCKDOWN TECHNIQUES; INTERFERON-GAMMA; MAREK DISEASE; POULTRY DISEASES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRAL VACCINES;

EID: 84923261676     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Calnek BW. Patogenesis of Marek’s disease virus infection. Curr Top Microbiol Immunol 2001;255:25–55.
2. Haq K, Brisbin JT, Thanthrige-Don N, Heidari M, Sharif S. Transcriptome and proteome profiling of host responses to Marek’s disease virus in chickens. Vet Immunol Immunopathol 2010;138:292–302.
3. Xing Z, Schat KA. Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek’s disease virus. J Virol 2000;74:3605–3612.
4. Abdul-Careem MF, Hunter BD, Parvizi P, Haghighi HR, Thanthrige-Don N, Sharif S. Cytokine gene expression patterns associated with immunization against Marek’s disease in chickens. Vaccine 2007;25:424–432.
5. Haq K, Elawadli I, Parvizi P, Mallick AI, Behboudi S, Sharif S. Interferon-gamma influences immunity elicited by vaccines against very virulent Marek’s disease virus. Antiviral Res 2011; 90:218–226.
6. Gonçalves M. Adeno-associated virus: From defective virus to effective vector. Virol J 2005;2:43.
7. Stilwell JL, Samulski RJ. Adeno-associated virus vectors for therapeutic gene transfer. Biotechniques 2003;34:148–50,152,154 passim.
8. McCarty DM, Young SM, Samulski RJ. Integration of adenoassociated virus (AAV) and recombinant AAV vectors. Annu Rev Genet 2004;38:819–845.
9. Yates VJ, El-Mishad AM, McCormick KJ, Trentin JJ. Isolation and characterization of an avian adenovirus-associated virus. Infect Immun 1973;7:973–980.
10. Bossis I, Chiorini JA. Cloning of an avian adeno-associated virus (AAAV) and generation of recombinant AAAV particles. J Virol 2003;77:6799–6810.
11. Estevez C, Villegas P. Sequence analysis, viral rescue from infectious clones and generation of recombinant virions of the avian adeno-associated virus. Virus Res 2004;105:195–208.
12. Estevez C, Villegas P. Recombinant avian adeno-associated virus: Transgene expression in vivo and enhancement of expression in vitro. Avian Dis 2006;50:216–221.
13. Wang AP, Sun HC, Wang JY, Wang YJ, Yuan WF. Recombinant avian adeno-associated virus-mediated oviduct-specific expression of recombinant human tissue kallikrein. Poult Sci 2008;87:777–782.
14. Perozo F, Villegas P, Estevez C, Alvarado IR, Purvis LB, Williams S. Protection against infectious bursal disease virulent challenge conferred by a recombinant avian adeno-associated virus vaccine. Avian Dis 2008;52:315–319.
15. Abdul-Careem MF, Hunter BD, Nagy E, et al. Development of a real-time PCR assay using SYBR Green chemistry for monitoring Marek’s disease virus genome load in feather tips. J Virol Methods 2006;133:34–40.
16. Haq K, Wootton SK, Barjesteh N, et al. Small interfering RNAmediated knockdown of chicken interferon-g expression. J Interferon Cytokine Res 2013;33:319–327.
17. Rohr UP, Wulf MA, Stahn S, Steidl U, Haas R, Kronenwett R. Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR. J Virol Methods 2002;106:81–88.
18. Witter RL, Schat KA. Marek’s disease. In: Saif YM, ed. Diseases of Poultry. Ames, Iowa: Iowa State University Press, Blackwell Publishing, 2003:407–467.
19. Calnek BW, Adldinger HK, Kahn DE. Feather follicle epithelium: A source of enveloped and infectious cell-free herpesvirus from Marek’s disease. Avian Dis 1970;14:219–233.
20. Abdul-Careem MF, Haq K, Shanmuganathan S, et al. Induction of innate host responses in the lungs of chickens following infection with a very virulent strain of Marek’s disease virus. Virology 2009;393:250–257.
21. Abdul-Careem MF, Read LR, Parvizi P, Thanthrige-Don N, Sharif S. Marek’s disease virus-induced expression of cytokine genes in feathers of genetically defined chickens. Dev Comp Immunol 2009;33:618–623.
22. Haq K, Abdul-Careem MF, Shanmuganathan S, Thanthrige-Don N, Read LR, Sharif S. Vaccine-induced host responses against very virulent Marek’s disease virus infection in the lungs of chickens. Vaccine 2010;28:5565–5572.
23. Gimeno IM, Cortes AL. Chronological study of cytokine transcription in the spleen and lung of chickens after vaccination with serotype 1 Marek’s disease vaccines. Vaccine 2011;29:1583–1594.
24. Perozo F, Villegas P, Estevez C, Alvarado IR, Purvis LB, Saume E. Avian adeno-associated virus-based expression of Newcastle disease virus hemagglutinin-neuraminidase protein for poultry vaccination. Avian Dis 2008;52:253–259.
25. Wang Y, Sun H, Shen P, Zhang X, Xia X. Effective inhibition of infectious bursal disease virus replication by recombinant avian adeno-associated virus-delivered microRNAs. J Gen Virol 2009;90:1417–1422.
26. Dong JY, Fan PD, Frizzell RA. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum Gene Ther 1996;7:2101–2012.
27. Kudo T, Sutou S. Usage of putative chicken U6 promoters for vector-based RNA interference. J Reprod Dev 2005;51:411–417.
28. Bannister SC, Wise TG, Cahill DM, Doran TJ. Comparison of chicken 7SK and U6 RNA polymerase III promoters for short hairpin RNA expression. BMC Biotechnol 2007;7:79.
29. Wang L, Wang H, Bell P, et al. Systematic evaluation of AAV vectors for liver directed gene transfer in murine models. Mol Ther 2010;18:118–125.
30. Biggs PM. The history and biology of Marek’s disease virus. Curr Top Microbiol Immunol 2001;255:1–24.
31. Weining KC, Schultz U, Münster U, Kaspers B, Staeheli P. Biological properties of recombinant chicken interferon-gamma. Eur J Immunol 1996;26:2440–2447.
32. Ikeda H, Old LJ, Schreiber RD. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev 2002;13:95–109.
33. Plachý J, Weining KC, Kremmer E, et al. Protective effects of type I and type II interferons toward Rous sarcoma virus-induced tumors in chickens. Virology 1999;256:85–91.
34. Abdul-Careem MF, Hunter BD, Sarson AJ, et al. Host responses are induced in feathers of chickens infected with Marek’s disease virus. Virology 2008;370:323–332.
35. Calnek BW. Lymphomagenesis in Marek’s disease. Avian Pathol 1998;27:S54–S64.
36. Cheeseman JH, Lillehoj HS, Lamont SJ. Reduced nitric oxide production and iNOS mRNA expression in IFN-gamma stimulated chicken macrophages transfected with iNOS siRNAs. Vet Immunol Immunopathol 2008;125:375–380.